CTNM

Profile

Full Name

Contineum Therapeutics, Inc.

Ticker Symbol

CTNM

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

Indexes

Not included

Website

http://www.contineum-tx.com

Employees

41

Key Details

Price

$4.15(+4.01%)

Market cap

$107.37M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.18(-359.62% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.15
CTNM price is $4.15

30-Day Relative Volume

0.89
CTNM 30-day relative volume is 0.89

Price Performance

Price Today change

+4.01%
CTNM price is up +4.01% today

Price YTD change

-71.67%
CTNM price is down -71.67% since January 1st

Price 1-year change

-71.59%
CTNM price is down -71.59% year-on-year

Price 3-year change

-
CTNM price 3-year change is unknown

Price Range

Price All-time high

$22.00
CTNM price is currently -81.14% below its historical high of $22.00

Price 3-year low

$3.91
CTNM price is currently +6.14% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$107.37M
CTNM market capitalization is $107.37 million

Market cap 3-year change

-
CTNM market capitalization 3-year change is unknown

Market cap All-time high

$565.44M
CTNM market capitalization is currently -81.01% below its historical high of $565.44 million

Market cap sector rank

49.42%
CTNM market capitalization is higher than 49.42% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.95%
CTNM shares outstanding is up +2.95% year-on-year

Shares Outstanding 3-Year Change

-
CTNM shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.88
CTNM beta is 0.88

200-day SMA

$14.37
CTNM price is currently -71.13% below its 200-day simple moving average

50-day SMA

$7.07
CTNM price is currently -41.34% below its 50-day simple moving average

RSI

22.48
CTNM 14-day relative strength index is 22.48

Volume

0.89
CTNM 30-day relative volume is 0.89

ATR

$0.54
CTNM average true range is $0.54

10-day Historical Volatility

78.98%
CTNM 10-day historical volatility is 78.98%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
CTNM annual revenue value is unknown

Revenue Analysts estimate

$7.50M
CTNM annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
CTNM annual revenue 1-year change is unknown

Revenue Sector rank

-
CTNM annual revenue is unknown

EPS

EPS

-$2.18
CTNM annual earnings per share is -$2.18

EPS Analysts estimate

-$2.19
CTNM annual earnings per share is currently -0.55% lower than the consensus analysts' forecast

EPS 1-year change

-359.62%
CTNM annual earnings per share is down -359.62% year-on-year

EPS Sector rank

36.81%
CTNM annual earnings per share is higher than 36.81% of companies in Healthcare sector

Profit

Gross profit

-
CTNM annual gross profit value is unknown

Gross margin

-
CTNM annual gross profit margin value is unknown

Operating profit

-$50.89M
CTNM annual operating income is -$50.89 million

Operating margin

-
CTNM annual operating profit margin value is unknown

Net income

-$42.26M
CTNM annual net profit is -$42.26 million

Net margin

-
CTNM annual net profit margin value is unknown

Expenses

Total expenses

$50.89M
CTNM annual total expenses is $50.89 million

Operating expenses

$50.89M
CTNM annual total operating expenses is $50.89 million

Cost of goods sold

-
CTNM annual cost of goods sold value is unknown

Selling, general & administrative expenses

$12.47M
CTNM annual SGA is $12.47 million

Depreciation and amortization

$258.00K
CTNM annual depreciation & amortization is $258.00 thousand

Interest expense

$0.00
CTNM annual interest expense is $0.00

Income tax

$0.00
CTNM annual income tax is $0.00

EBIT & EBITDA

EBIT

-$42.26M
CTNM annual earnings before interest & taxes is -$42.26 million

EBITDA

-$42.00M
CTNM annual EBITDA is -$42.00 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$212.85M
CTNM annual total assets is $212.85 million

Non current assets

$6.46M
CTNM annual long term assets is $6.46 million

Current assets

$206.39M
CTNM annual total current assets is $206.39 million

Cash and cash equivalents

$21.94M
CTNM annual cash & cash equivalents is $21.94 million

Accounts receivable

-
CTNM annual accounts receivable value is unknown

Inventory

-
CTNM annual inventory value is unknown

Liabilities

Total liabilities

$14.78M
CTNM annual total liabilities is $14.78 million

Long term liabilities

$4.81M
CTNM annual total long term liabilities is $4.81 million

Current liabilities

$9.97M
CTNM annual total current liabilities is $9.97 million

Accounts payable

$1.81M
CTNM annual accounts payable is $1.81 million

Debt

Total debt

$6.26M
CTNM annual total debt is $6.26 million

Total debt 1-year change

+994.23%
CTNM annual total debt is up +994.23% year-on-year

Long term debt

$4.81M
CTNM annual long term debt is $4.81 million

Short term debt

$1.45M
CTNM annual short term debt is $1.45 million

Equity & Capital

Shareholders equity

$198.07M
CTNM annual stockholders equity is $198.07 million

Book value

$198.07M
CTNM annual book value is $198.07 million

Retained earnings

-$117.40M
CTNM annual retained earnings is -$117.40 million

Working capital

$196.41M
CTNM annual working capital is $196.41 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$32.84M
CTNM annual cash flow from operations is -$32.84 million

Cash from operations 1-year change

-269.75%
CTNM annual cash flow from operations is down -269.75% year-on-year

Cash from investing

-$69.74M
CTNM annual cash flow from investing activities is -$69.74 million

Cash from investing 1-year change

-6.36%
CTNM annual cash flow from investing activities is down -6.36% year-on-year

Cash from financing

$109.00M
CTNM annual cash flow from financing activities is $109.00 million

Cash from financing 1-year change

+94.03%
CTNM annual cash flow from financing activities is up +94.03% year-on-year

CAPEX

CAPEX

-
CTNM annual capital expenditures value is unknown

CAPEX 1-year change

-
CTNM annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$33.36M
CTNM annual free cash flow is -$33.36 million

Free cash flow 1-year change

-276.18%
CTNM annual free cash flow is down -276.18% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CTNM annual gross profit margin value is unknown

Operating margin

-
CTNM annual operating profit margin value is unknown

Net margin

-
CTNM annual net profit margin value is unknown

ROA & ROE

ROA

-19.85%
CTNM annual return on assets is -19.85%

ROE

-21.34%
CTNM annual return on equity is -21.34%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CTNM price to earnings ratio value is unknown

PE ratio Sector rank

-
CTNM price to earnings ratio is unknown

PB Ratio

PB ratio

0.54
CTNM price to book ratio is 0.54

PB ratio Sector rank

31.36%
CTNM price to book ratio is higher than 31.36% of companies in Healthcare sector

PS Ratio

PS ratio

-
CTNM price to sales ratio value is unknown

PS ratio Sector rank

-
CTNM price to sales ratio is unknown

Enterprise value

Enterprise value

$91.68M
CTNM enterprise value is $91.68 million

Enterprise value Sector rank

49.09%
CTNM enterprise value is higher than 49.09% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.18
CTNM EV/EBITDA is -2.18

EV/EBITDA Sector rank

30.35%
CTNM EV/EBITDA is higher than 30.35% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

20.69
CTNM annual current ratio is 20.69

Quick ratio

-
CTNM annual quick ratio value is unknown

Leverage

Debt to equity

0.03
CTNM annual debt to equity ratio is 0.03

Interest coverage ratio

-
CTNM annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CTNM piotroski f-score value is unknown

Altman Z-Score

-
CTNM altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 13, 25 Jones Trading
Buy
Mar 7, 25 Baird
Outperform
Jan 9, 25 RBC Capital
Outperform
Nov 7, 24 RBC Capital
Outperform
Oct 22, 24 Baird
Outperform
Aug 14, 24 RBC Capital
Outperform
Apr 30, 24 Stifel
Buy
Apr 30, 24 RBC Capital
Outperform
Apr 30, 24 Morgan Stanley
Overweight

Institutional Ownership

Similar stocks

SLS logo
SELLAS Life Sciences (SLS)
TNXP logo
Tonix Pharmaceuticals Holding (TNXP)
AIRS logo
AirSculpt Technologies (AIRS)
INFU logo
InfuSystem Holdings (INFU)
ENTA logo
Enanta Pharmaceuticals (ENTA)
IRWD logo
Ironwood Pharmaceuticals (IRWD)
FATE logo
Fate Therapeutics (FATE)
LCTX logo
Lineage Cell Therapeutics (LCTX)
OBIO logo
Orchestra BioMed Holdings (OBIO)
  • What is the ticker symbol for Contineum Therapeutics Class A?
  • Does Contineum Therapeutics Class A pay dividends?
  • What sector is Contineum Therapeutics Class A in?
  • What industry is Contineum Therapeutics Class A in?
  • What country is Contineum Therapeutics Class A based in?
  • Is Contineum Therapeutics Class A in the S&P 500?
  • Is Contineum Therapeutics Class A in the NASDAQ 100?
  • Is Contineum Therapeutics Class A in the Dow Jones?
  • When was Contineum Therapeutics Class A's last earnings report?
  • When does Contineum Therapeutics Class A report earnings?
  • Should I buy Contineum Therapeutics Class A stock now?

What is the ticker symbol for Contineum Therapeutics Class A?

The ticker symbol for Contineum Therapeutics Class A is NASDAQ:CTNM

Does Contineum Therapeutics Class A pay dividends?

No, Contineum Therapeutics Class A does not pay dividends

What sector is Contineum Therapeutics Class A in?

Contineum Therapeutics Class A is in the Healthcare sector

What industry is Contineum Therapeutics Class A in?

Contineum Therapeutics Class A is in the Biotechnology industry

What country is Contineum Therapeutics Class A based in?

Contineum Therapeutics Class A is headquartered in United States

Is Contineum Therapeutics Class A in the S&P 500?

No, Contineum Therapeutics Class A is not included in the S&P 500 index

Is Contineum Therapeutics Class A in the NASDAQ 100?

No, Contineum Therapeutics Class A is not included in the NASDAQ 100 index

Is Contineum Therapeutics Class A in the Dow Jones?

No, Contineum Therapeutics Class A is not included in the Dow Jones index

When was Contineum Therapeutics Class A's last earnings report?

Contineum Therapeutics Class A's most recent earnings report was on Mar 6, 2025

When does Contineum Therapeutics Class A report earnings?

The next expected earnings date for Contineum Therapeutics Class A is May 30, 2025

Should I buy Contineum Therapeutics Class A stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page